Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine

Viral Immunol. 1996;9(4):241-5. doi: 10.1089/vim.1996.9.241.

Abstract

Subjects > or = 55 years of age were immunized with attenuated varicella zoster virus (VZV) vaccine (live) or with the same vaccine, which had been heated to 56 degrees C for 7 days (killed). The ability of subjects' blood lymphocytes to lyse target cells infected with VZV was determined before and 3 months after immunization using autologous Epstein-Barr virus (EBV) lymphoblasts as targets for human leukocyte antigen (HLA) class I restricted cytotoxicity and human fibroblasts as targets for unrestricted (natural killer [NK]) cytotoxicity. The live vaccine recipients showed an increase in their class I-restricted lysis of targets compared with the recipients of the killed vaccine. The two populations showed equivalent increase in their NK-dependent lysis of fibroblast targets. The results support the view that both the live and killed vaccines stimulate cytotoxicity by VZV-specific lymphocytes but that the live vaccine stimulates relatively more class I-restricted killing.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • B-Lymphocytes / cytology
  • B-Lymphocytes / immunology*
  • Cells, Cultured
  • Cytotoxicity Tests, Immunologic
  • Herpesvirus 3, Human / immunology*
  • Herpesvirus 4, Human / immunology
  • Histocompatibility Antigens Class I / immunology*
  • Humans
  • Immunization
  • Killer Cells, Natural / immunology*
  • Middle Aged
  • Vaccines, Attenuated / immunology*
  • Vaccines, Inactivated / immunology*
  • Viral Envelope Proteins / immunology
  • Viral Vaccines / immunology*

Substances

  • Histocompatibility Antigens Class I
  • Vaccines, Attenuated
  • Vaccines, Inactivated
  • Viral Envelope Proteins
  • Viral Vaccines
  • glycoprotein IV, varicella-zoster virus